| Acquired by | Swedish Orphan Biovitrum |
| Price | $493M |
| Date | 11/09 |
| Website | biovitrum.com |
| Category | BioTech |
| Phone | +46 8 697 20 00 |
| Employees | |
| Founded | 2001 |
Biovitrum is an international pharmaceutical company that markets specialist pharmaceuticals in several regions globally.
Using its expertise and experience Biovitrum takes scientific innovation to patients with significant unmet medical need. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within our prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption.
The company has revenues of approximately SEK 1.2 billion and around 400 employees. The company head office is located in Sweden.
In 2009, Biovitrum merged with Swedish Orphan, and the combined company has subsequently been rebranded as Swedish Orphan Biovitrum.
